August 29, 2018
Corium to Present at the H.C. Wainwright 20th Annual Global Investment Conference
MENLO PARK, Calif. , Aug. 29, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…